Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Gerwyn Morris, Michael Berk
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging
Sunil J. Wimalawansa
Biology (2019) Vol. 8, Iss. 2, pp. 30-30
Open Access | Times Cited: 351
Nutritional psychiatry: the present state of the evidence
Wolfgang Marx, Genevieve Moseley, Michael Berk, et al.
Proceedings of The Nutrition Society (2017) Vol. 76, Iss. 4, pp. 427-436
Open Access | Times Cited: 334
Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Yuri Milaneschi, Femke Lamers, Michael Berk, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 5, pp. 369-380
Closed Access | Times Cited: 302
Redox regulation of the immune response
Gerwyn Morris, Maria Gevezova, Victoria Sarafian, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 10, pp. 1079-1101
Open Access | Times Cited: 250
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease
Gerwyn Morris, Michael Berk, André F. Carvalho, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 6, pp. 4432-4451
Closed Access | Times Cited: 248
Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities
Anastasiya Slyepchenko, Michaël Maes, Felice N. Jacka, et al.
Psychotherapy and Psychosomatics (2016) Vol. 86, Iss. 1, pp. 31-46
Open Access | Times Cited: 246
Vitamin D deficiency and diabetes
Michael J. Berridge
Biochemical Journal (2017) Vol. 474, Iss. 8, pp. 1321-1332
Open Access | Times Cited: 239
Cognitive remission: a novel objective for the treatment of major depression?
Beatrice Bortolato, Kamilla Woznica Miskowiak, Cristiano A. Köhler, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 223
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 206
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
Shannon Rose, Dmitriy Niyazov, Daniel A. Rossignol, et al.
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 5, pp. 571-593
Open Access | Times Cited: 201
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66
Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
de Melo, Sandra Odebrecht Vargas Nunes, George Anderson, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 78, pp. 34-50
Closed Access | Times Cited: 163
Vitamin D and Depression: Cellular and Regulatory Mechanisms
Michael J. Berridge
Pharmacological Reviews (2017) Vol. 69, Iss. 2, pp. 80-92
Open Access | Times Cited: 157
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Angela Trovato Salinaro, Manuela Pennisi, Rosanna Di Paola, et al.
Immunity & Ageing (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 146
Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases
Gerwyn Morris, Michael Berk, André F. Carvalho, et al.
Behavioural Brain Research (2017) Vol. 341, pp. 154-175
Closed Access | Times Cited: 141
A model of the mitochondrial basis of bipolar disorder
Gerwyn Morris, Ken Walder, Sean L. McGee, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 74, pp. 1-20
Closed Access | Times Cited: 140
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson’s Disease?
Andrea Herrera Ronda, Patricia Muñoz, Harry W.M. Steinbusch, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 4, pp. 702-711
Closed Access | Times Cited: 129
Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists
Gerwyn Morris, Adam J. Walker, Michael Berk, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 7, pp. 5767-5786
Open Access | Times Cited: 125
Leaky brain in neurological and psychiatric disorders: Drivers and consequences
Gerwyn Morris, Brisa S. Fernandes, Basant K. Puri, et al.
Australian & New Zealand Journal of Psychiatry (2018) Vol. 52, Iss. 10, pp. 924-948
Open Access | Times Cited: 121
The Depressed Frail Phenotype: The Clinical Manifestation of Increased Biological Aging
Patrick J. Brown, Bret R. Rutherford, Kristine Yaffe, et al.
American Journal of Geriatric Psychiatry (2016) Vol. 24, Iss. 11, pp. 1084-1094
Open Access | Times Cited: 110
Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome
Gerwyn Morris, Michael Berk, Hans Klein, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 6, pp. 4271-4291
Closed Access | Times Cited: 102
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Gerwyn Morris, Basant K. Puri, Adam J. Walker, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 862-882
Closed Access | Times Cited: 98
The Role of Maternal Immune Activation in the Pathogenesis of Autism: A Review of the Evidence, Proposed Mechanisms and Implications for Treatment
Aleksandra Zawadzka, Magdalena Cieślik, Agata Adamczyk
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11516-11516
Open Access | Times Cited: 96
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia
Brooke E. Hjelm, Brandi Rollins, Firoza Mamdani, et al.
Complex Psychiatry (2015) Vol. 1, Iss. 4, pp. 201-219
Open Access | Times Cited: 93
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Michael Berk, Alyna Turner, Gin S. Malhi, et al.
BMC Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top